Multiomic profiling of cardiometabolic diseases (Illumina)

PresolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in BETHESDA, MD
  • Industry: Research and Development in Biotechnology (except Nanobiotechnology)
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
75N98026Q00733
Opportunity Type
Presolicitation
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Posted Date
Wednesday, July 1, 2026
Response Deadline
Monday, July 13, 2026
PSC Code
6505
Set-Aside
No Set Aside
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

Requirements: Purpose and Objectives: This order is for methylation and genotyping arrays produced and manufactured by Illumina. The methylation beadchips are designed specifically for studying methylation changes across the genome while the genotyping arrays are designed for studying genetic variation across the genome. The Center for Research on Genomics and Global Health will use methylation beadchips and genotyping arrays to study gene methylation, genetic variations, and methylation quantitative traits in previously recruited participants. The methylation and genotypes will be generated by the NHGRI Genomics Core, which has the necessary equipment and expertise for efficient processing of Illumina SNP beadchips. The Core has an Illumina iScan, Illumina Autoloader, and a Tecan Liquid H

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.